Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for Inflammation in Hemodialysis
NCT00529633Phase 3Terminated
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in Systemic Inflammatory Response Syndrome (SIRS), hypoalbuminemia. Started Sep 2007; status: terminated.
02
Drugs
thalidomide
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)hypoalbuminemia
Beyond the preview
Go deeper on NCT00529633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529633.